Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors

Proc Natl Acad Sci U S A. 1990 Sep;87(17):6902-6. doi: 10.1073/pnas.87.17.6902.

Abstract

We analyzed the normal/mutated allelic ratio of the Ha-ras-1 gene in mouse skin squamous cell carcinomas induced by initiation with dimethylbenz[a]anthracene and promotion with phorbol 12-myristate 13-acetate. DNA for these studies was obtained from short-term tumor cultures (24-72 hr) to eliminate the contribution of stromal and inflammatory cells to the sample. The allelotypic analysis was performed in 25 squamous cell carcinomas by quantitative radio-analysis of the Xba I restriction fragment length polymorphism as detected by BS9, a v-Ha-ras probe, and rehybridization of the Southern blots with probes for chromosomes 7 and 8. Approximately 85% of the tumors presented overrepresentation of the mutated allele in the form of 1 normal/2 mutated (12 tumors), 0 normal/3 mutated (4 tumors), 0 normal/2 mutated (3 tumors), and gene amplification (3 tumors). No tumor was found with a 2 normal/1 mutated allelic ratio. These results support our previous cytogenetic studies, indicating that trisomy of chromosome 7 is present in the majority of these tumors and show that nonrandom duplication of the chromosome carrying the mutated Ha-ras-1 allele appears to be a major mechanism by which the mutated gene is overrepresented.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene
  • Alleles
  • Animals
  • Carcinoma, Squamous Cell / chemically induced
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Cell Differentiation
  • Cell Transformation, Neoplastic
  • Chromosome Mapping*
  • Gene Amplification
  • Genes, ras*
  • Immunoenzyme Techniques
  • Keratins / analysis
  • Mice
  • Mice, Inbred Strains
  • Models, Genetic
  • Mutation
  • Nucleic Acid Hybridization
  • Polymorphism, Restriction Fragment Length
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology

Substances

  • 9,10-Dimethyl-1,2-benzanthracene
  • Keratins